additional nimodipine ( in the first group ) , a calcium antagonist commonly recommended for preventing vasospasm and consequent neurologic deficits after subarachnoid hemorrhage , not only reduced the need for nnp , a vasodilating drug with potential toxicity , by 70 % -80 % as compared to the second group ( table 1 ) .
C0028094
nimodipine
C0038525
subarachnoid hemorrhage